Bio-Me to receive Aleap Pre-Seed Fund

Bio-Me is pleased to announce that it has been selected as the recipient of Aleap Pre-Seed Fund. The company was selected as one of four companies from more than 50 applicants. The Aleap Pre-Seed Fund will make a NOK 1.25 million equity investment in Bio-Me, based on the fact that the company has succeeded in matching that amount from existing and new investors.

“The Aleap Pre-Seed Fund and matching capital makes it possible for Bio-Me to continue and accelerate its development program. We have already generated exciting new data that demonstrates the power of our Precision Microbiome Profiling platform, and with these resources, we will be able to further accelerate market introduction”, states Dr. Morten Isaksen. Founder and CEO of Bio-Me.

About Aleap:

Aleap was established in 2016 and has in a short time grown to become Norway’s largest incubator for health startups. It helps ambitious entrepreneurs in the development of high-growth healthcare companies.

Aleap is a national hub for health innovation and is located in the Oslo Research Parks.